PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

60 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... 3 ... ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
21.
Köchert, K.* et al.: High-level expression of Mastermind-like 2 contributes to aberrant activation of the NOTCH signaling pathway in human lymphomas. Oncogene 30, 1831-1840 (2011)
22.
Tanori, M.* et al.: Opposite modifying effects of HR and NHEJ deficiency on cancer risk in Ptc1 heterozygous mouse cerebellum. Oncogene 30, 4740-4749 (2011)
23.
Scheller, H. et al.: c-Myc overexpression promotes a germinal center-like program in Burkitt's lymphoma. Oncogene 29, 888-897 (2010)
24.
Wolf, M.J.* ; Seleznik, G.M.* ; Zeller, N.* & Heikenwälder, M.: The unexpected role of lymphotoxin β receptor signaling in carcinogenesis: From lymphoid tissue formation to liver and prostate cancer development. Oncogene 29, 5006-5018 (2010)
25.
Banjac, A. et al.: The cystine/cysteine cycle: A redox cycle regulating susceptibility versus resistance to cell death. Oncogene 27, 1618-1628 (2008)
26.
Ehrhardt, H.* et al.: Cytotoxic drug-induced, p53-mediated upregulation of caspase-8 in tumor cells. Oncogene 27, 783-793 (2008)
27.
Engelmann, A.* ; Speidel, D.* ; Bornkamm, G.W. ; Deppert, W.* & Stocking, C.*: Gadd45β is a pro-survival factor associated with stress-resistant tumors. Oncogene 27, 1429-1438 (2008)
28.
Greif, P.A. ; Tizazu, B.* ; Krause, A.J. ; Kremmer, E. & Bohlander, S.K.: The leukemogenic CALM/AF10 fusion protein alters the subcellular localization of the lymphoid regulator Ikaros. Oncogene 27, 2886-2896 (2008)
29.
Härtl, B.* ; Zeller, T.* ; Blanchette, P.* ; Kremmer, E. & Dobner, T.*: Adenovirus type 5 early region 1B 55-kDa oncoprotein can promote cell transformation by a mechanism independent from blocking p53-activated transcription. Oncogene 27, 3673-3684 (2008)
30.
Unger, K. et al.: Array CGH demonstrates characteristic aberration signatures in human papillary thyroid carcinomas governed by RET/PTC. Oncogene 27, 4592-4602 (2008)
31.
Hausherr, A. et al.: Inhibition of IL-6-dependent growth of myeloma cells by an acidic peptide repressing the gp130-mediated activation of Src family kinases. Oncogene 26, 4987-4998 (2007)
32.
Thirunarayanan, N.* et al.: Enhanced tumorigenicity of fibroblasts transformed with human herpesvirus 8 chemokine receptor vGPCR by successive passage in nude and immunocompetent mice. Oncogene 26, 5702-5712 (2007)
33.
Trivedi, A.K.* et al.: Proteomic identification of C/EBP-DBD multiprotein complex: JNK1 activates stem cell regulator C/EBPalpha by inhibiting its ubiquitination. Oncogene 26, 1789-1801 (2007)
34.
Djafarzadeh, R.* et al.: GPI-anchored TIMP-1 treatment renders renal cell carcinoma sensitive to FAS-mediated killing. Oncogene 25, 1496-1508 (2006)
35.
Dolznig Grebien, F.* et al.: Erythroid progenitor renewal versus differentiation: Genetic evidence for cell autonomous, essential functions of EpoR, STat5 and the GR. Oncogene 25, 2890-2900 (2006)
36.
Fröhlich Archangelo, L.* ; Gläsner, J.* ; Krause, A.* & Bohlander, S.K.: The novel CALM interactor CATS influences the subcellular localization of the leukemogenic fusion protein CALM/AF10. Oncogene 25, 4099-4109 (2006)
37.
Pazzaglia, S.* et al.: Linking DNA damage to medulloblastoma tumorigenesis in patched heterozygous knockout mice. Oncogene 25, 1165-1173 (2006)
38.
Dirmeier, U. et al.: Latent membrane protein 1 of Epstein-Barr virus coordinately regulates proliferation with control of apoptosis. Oncogene 24, 1711-1717 (2005)
39.
Weiss, C.* et al.: TCDD induces c-jun expression via a novel Ah (dioxin) receptor-mediated p38-MAPK-dependent pathway. Oncogene 24, 4975-4983 (2005)
40.
Yu, M.* et al.: PARP-10, a novel Myc-interacting protein with poly(ADP-ribose) polymerase activity, inhibits transformation. Oncogene 24, 1982-1993 (2005)
▮◀ ◀◀ 1 ... 2 ... 3 ... ▶▶ ▶▮